Target intelligence / Profile preview

Intestinal and oral microbiome community

Molecular classification
Other
01

Overview

The intestinal and oral microbiome community refers to the vast and diverse collection of microorganisms, including bacteria, archaea, fungi, and viruses, that reside in the human gastrointestinal and oral cavities. This complex ecosystem functions as a dynamic biological entity, performing essential roles such as the fermentation of non-digestible dietary fibers, synthesis of vitamins (e.g., Vitamin K and B12), and the maturation of the host's mucosal immune system [1, 2]. The oral microbiome serves as the primary gateway to the GI tract, and its composition can significantly influence the downstream intestinal environment through the translocation of species and metabolites [3]. Dysbiosis, characterized by a loss of microbial diversity or an overgrowth of pathobionts, is fundamentally linked to the pathogenesis of Clostridioides difficile infection, inflammatory bowel disease (IBD), periodontitis, and systemic metabolic disorders [4, 5]. Therapeutic strategies targeting this community include the use of narrow-spectrum antibiotics, prebiotics, probiotics, and fecal microbiota transplantation (FMT) to restore ecological homeostasis [6]. Recent clinical successes, such as the FDA approval of microbiota-based products for recurrent infections, underscore the community's role as a critical therapeutic target in modern medicine [7]. Sources: [1] NIH Human Microbiome Project (2012); [2] Belkaid & Hand (2014) Cell; [3] Park et al. (2021) Front Cell Infect Microbiol; [4] Lynch & Pedersen (2016) NEJM; [5] Fan & Pedersen (2021) Nat Rev Microbiol; [6] Kho & Lal (2018) Front Microbiol; [7] Khanna et al. (2022) Drugs.

Other names
Gut-oral axisHuman microbiotaCommensal floraGastrointestinal microbiomeOral microbiomeIntestinal flora
02

Mechanism of action

Restoration of microbial diversity and ecological balance, competitive exclusion of pathogenic species, modulation of host immune signaling through Toll-like receptors, and production of bioactive metabolites such as short-chain fatty acids (SCFAs) [5, 6].

03

Biological functions

MetabolismImmune responsePathogen protectionNutrient absorptionBarrier maintenanceSignal transductionVitamin synthesis
04

Disease associations

InfectionInflammationCancerMetabolic syndromeNeurodegenerative diseaseCardiovascular diseaseAutoimmune disease
05

Safety considerations

Risk of unintended pathogen transmission (e.g., MDROs)Bacteremia or sepsis in immunocompromised patientsLong-term ecological disruptionVariable patient response and engraftmentPotential for systemic inflammatory response
06

Interacting drugs

Vancomycin

8 more in the full profile.

07

Biomarkers

Alpha diversity index (Shannon/Simpson)Beta diversity indexFirmicutes/Bacteroidetes ratioAkkermansia muciniphila abundanceFecal calprotectinShort-chain fatty acid levelsTrimethylamine N-oxide (TMAO) levels

Beyond the preview

Go deeper on Intestinal and oral microbiome community.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal and oral microbiome community.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call